13 Dokumente gefunden

22 - SOS vom Herz – der Herzinfarkt

Unser Herz arbeitet rund um die Uhr. Etwa 100.000 Mal schlägt es am Tag und versorgt den Körper mit Sauerstoff und Nährstoffen. Im Alltag nehmen wir davon kaum etwas wahr. Erst wenn das Herz aus dem Takt gerät, rückt es in den Fokus. Eine der häufigsten chronischen Herzerkrankungen ist die sogenannte…
Jena: Universitätsklinikum, 2026-03-30

Less intensive lipid-lowering therapy after ST-elevation myocardial infarction is associated with cardiovascular events :…

Abstract Background “Jena auf Ziel” (“JaZ”) is a prospective cohort study in patients with ST-elevation myocardial infarction (STEMI). Early combination of a statin and ezetimibe was initiated on the day of admission and lipid-lowering therapy (LLT) was escalated during follow-up with bempedoic acid…
Berlin: Springer, 2026-02

LipidSnapshot – Treatment gaps in hypercholesterolemia in patients with atherosclerotic cardiovascular disease documented…

Abstract Aims Office-based cardiologists (OBCs) and general practitioners (GPs) follow different approaches for hypercholesterolemia management in atherosclerotic cardiovascular disease (ASCVD). This study evaluates whether differences in clinical practice between OBCs and GPs contribute to existing…
Berlin: Springer, 2026-02

Perfusion und Oxygenierung des Sehnervenkopfes bei Glaukom

Zweck: Untersuchung der Hb-konzentration und Sauerstoffsättigung am Sehnervenkopf bei Glaukompatienten im Vergleich zu Kontrollen. Methoden: Einbezogen wurden 31 Patienten mit primärem Offenwinkelglaukom (Durchschnittsalter: 64,9 ± 2,1 Jahre) sowie 31 gesunden Kontrollpersonen (65,5 ± 2,0 Jahre). Es…

Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation…

Abstract Background and aims Currently, less than 20% of patients at very high-risk achieve ESC/EAS dyslipidemia guideline-recommended LDL-C target levels in Europe. “Jena auf Ziel—JaZ” is a prospective cohort study in which early combination therapy with atorvastatin 80 mg and ezetimibe 10 mg was initiated…
Berlin: Springer, 2023-09

High interindividual variability in LDL-cholesterol reductions after inclisiran administration in a real-world multicenter…

Abstract Background and aims Low-density lipoprotein cholesterol (LDL-C) is the main therapeutic target in the treatment of hypercholesterolemia. Small interfering RNA (siRNA) inclisiran is a new drug, which targets PCSK9 mRNA in the liver, reducing concentrations of circulating LDL-C. In randomized…
Berlin: Springer, 2023-07-09

Phytosterols and Cardiovascular Risk Evaluated against the Background of Phytosterolemia Cases—A German Expert Panel Statement…

aus: Nutrients
Phytosterols (PSs) have been proposed as dietary means to lower plasma LDL-C. However, concerns are raised that PSs may exert atherogenic effects, which would offset this benefit. Phytosterolemia was thought to mimic increased plasma PSs observed after the consumption of PS-enriched foods. This expert…
Basel: MDPI, 2023-02-06

Different Perspectives of Patients and Physicians on LDL-C Target Achievement in the Treatment of Hypercholesterolemia :…

Aims: Low-density lipoprotein cholesterol (LDL-C) reduction in hypercholesterolemia patients at very high cardiovascular (CV) risk is essential in preventing future CV events. The objective was to assess the perception on hypercholesterolemia management in secondary prevention in Germany. Methods: PROCYON…
Tarporley: Springer Healthcare, 2023-02

Patient and Physician Reported Perception on Hypercholesterolemia Management in Primary Prevention in Germany : Results from…

Introduction: Effective hypercholesterolemia management is essential in primary prevention of cardiovascular events. The objective of PROCYON was to assess the perception on hypercholesterolemia management in primary prevention and to identify reasons for insufficient target attainment in clinical practice…
Tarporley: Springer Healthcare, 2022-09

Rationale and Design of JenaMACS—Acute Hemodynamic Impact of Ventricular Unloading Using the Impella CP Assist Device in…

Introduction: Cardiogenic shock due to myocardial infarction or heart failure entails a reduction in end organ perfusion. Patients who cannot be stabilized with inotropes and who experience increasing circulatory failure are in need of an extracorporeal mechanical support system. Today, small, percutaneously…
Basel: MDPI, 2022-08-08

Phytosterols and Cardiovascular Disease

Purpose of Review: Coronary heart disease is the leading cause of mortality worldwide. Elevated blood cholesterol levels are not only the major but also the best modifiable cardiovascular risk factor. Lifestyle modifications which include a healthy diet are the cornerstone of lipid-lowering therapy.…
Heidelberg [u.a.]: Springer, 2021-11

Gesättigte Fettsäuren und kardiovaskuläres Risiko : Ist eine Revision der Ernährungsempfehlungen angezeigt?

aus: Herz
Zusammenfassung Die „Fetthypothese der koronaren Herzkrankheit“, derzufolge „gesättigte Fettsäuren“ („saturated fatty acids“, SFA) die LDL(„low-density lipoprotein“)-Cholesterin-Konzentration (LDL-C) steigern und folglich das Risiko für kardiovaskuläre Erkrankungen erhöhen, prägte die Ernährungsempfehlungen…
München: Urban & Vogel, 2021-09-23